Dr. Konrad Hoeft

Dr. Konrad Hoeft is a Co-Founder of SequantrixTM. He is a nephrologist in training and resident physician at the Department of Nephrology and Clinical Immunology at the Uniklinik RWTH Aachen. He is also a Post-Doctoral Research Fellow at the Institute of Experimental Medicine and Systems Biology at Uniklinik RWTH Aachen. His research focuses on dissecting the molecular and cellular cues driving fibroblast activation to identify novel therapeutic approaches for fibrosis. Konrad was previously an MD Research Fellow at the Massachusetts General Hospital (Harvard Medical School). Konrad advises SequantrixTM on target science.